Research Topic · Peer-Reviewed

Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, encompassing several histological subtypes such as adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma, and it is distinguished from the less common small-cell lung cancer by its cell appearance and clinical behaviour. It arises…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 52× across the literature 🗓 Reviewed July 2026

Overview

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, encompassing several histological subtypes such as adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma, and it is distinguished from the less common small-cell lung cancer by its cell appearance and clinical behaviour. It arises from uncontrolled growth of cells in the lung tissue and can cause cough, breathlessness, chest pain, and weight loss, often presenting at an advanced stage when symptoms appear. Management depends on the stage and molecular features of the tumour and may combine surgery, chemotherapy, radiation therapy, targeted agents directed at specific genetic alterations, and immunotherapy, with early detection improving the prospects for treatment. NSCLC can spread to distant sites, including the adrenal glands, and research addresses its biology, prognostic markers, surgical approaches, and evolving systemic therapies. The journal publishes peer-reviewed work relevant to these themes, including studies on immunotherapy use and patterns of pulmonary resection, the role of heparin in lung cancer, lung cancer with isolated adrenal metastases, complex disease modelling for cancer biomarker development, the neutrophil-to-lymphocyte ratio as a prognostic indicator in related squamous-cell carcinoma, and broader work on cancer immunotherapy and prevention. Together these situate NSCLC within the wider study of thoracic oncology and cancer treatment.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

The Role of Heparin in Lung Cancer

Abu Arab WalidCorresponding author
Service de Chirurgie thoracique, Université de Sherbrooke, Québec, Canada
Exact topic Neoplasms Cited by 7 doi:10.14302/issn.2639-1716.jn-17-1499
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 52 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Non-Small Cell Lung Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Lung Cancer Epidemiology.

Journal editorial board
Krzysztof Roszkowski · Poland Peter Lee · United Kingdom Jonathan Riess · United States

This page summarises published research for orientation; it is not medical or professional advice.